搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O139:H28 Ecotin (eco) CSB-YP420935EJD
CSB-EP420935EJD
CSB-BP420935EJD
CSB-MP420935EJD
CSB-EP420935EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Probable 4-deoxy-4-formamido-L-arabinose-phosphoundecaprenol deformylase ArnD (arnD) CSB-YP420936EJD
CSB-EP420936EJD
CSB-BP420936EJD
CSB-MP420936EJD
CSB-EP420936EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Ribonuclease BN (rbn) CSB-YP420937EJD
CSB-EP420937EJD
CSB-BP420937EJD
CSB-MP420937EJD
CSB-EP420937EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 UPF0207 protein yfbR (yfbR) CSB-YP420938EJD
CSB-EP420938EJD
CSB-BP420938EJD
CSB-MP420938EJD
CSB-EP420938EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Chorismate synthase (aroC) CSB-YP420939EJD
CSB-EP420939EJD
CSB-BP420939EJD
CSB-MP420939EJD
CSB-EP420939EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Manganese transport protein MntH (mntH), partial CSB-YP420940EJD
CSB-EP420940EJD
CSB-BP420940EJD
CSB-MP420940EJD
CSB-EP420940EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Coproporphyrinogen-III oxidase, aerobic (hemF) CSB-YP420941EJD
CSB-EP420941EJD
CSB-BP420941EJD
CSB-MP420941EJD
CSB-EP420941EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP420942EJD
CSB-EP420942EJD
CSB-BP420942EJD
CSB-MP420942EJD
CSB-EP420942EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP420943EJD
CSB-EP420943EJD
CSB-BP420943EJD
CSB-MP420943EJD
CSB-EP420943EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Protein RnfH (rnfH) CSB-YP420944EJD
CSB-EP420944EJD
CSB-BP420944EJD
CSB-MP420944EJD
CSB-EP420944EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Protein RecA (recA) CSB-YP420945EJD
CSB-EP420945EJD
CSB-BP420945EJD
CSB-MP420945EJD
CSB-EP420945EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ispF) CSB-YP420946EJD
CSB-EP420946EJD
CSB-BP420946EJD
CSB-MP420946EJD
CSB-EP420946EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Sulfite reductase [NADPH] flavoprotein alpha-component (cysJ) CSB-YP420947EJD
CSB-EP420947EJD
CSB-BP420947EJD
CSB-MP420947EJD
CSB-EP420947EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Ribosomal RNA large subunit methyltransferase M (rlmM) CSB-YP420948EJD
CSB-EP420948EJD
CSB-BP420948EJD
CSB-MP420948EJD
CSB-EP420948EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 D-phenylhydantoinase (hyuA) CSB-YP420949EJD
CSB-EP420949EJD
CSB-BP420949EJD
CSB-MP420949EJD
CSB-EP420949EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Cell division protein ZapA (zapA) CSB-YP420950EJD
CSB-EP420950EJD
CSB-BP420950EJD
CSB-MP420950EJD
CSB-EP420950EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 UPF0301 protein yqgE (yqgE) CSB-YP420951EJD
CSB-EP420951EJD
CSB-BP420951EJD
CSB-MP420951EJD
CSB-EP420951EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB) CSB-YP420952EJD
CSB-EP420952EJD
CSB-BP420952EJD
CSB-MP420952EJD
CSB-EP420952EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 30S ribosomal protein S21 (rpsU) CSB-YP420953EJD
CSB-EP420953EJD
CSB-BP420953EJD
CSB-MP420953EJD
CSB-EP420953EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 D-tagatose-1,6-bisphosphate aldolase subunit kbaZ (kbaZ) CSB-YP420954EJD
CSB-EP420954EJD
CSB-BP420954EJD
CSB-MP420954EJD
CSB-EP420954EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>